Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1 Hepatorenal Syndrome”

12 trials

Showing 12 of 12 results

Post-approval studies (Phase 4)Study completedNCT03455322
What this trial is testing

Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.

Who this might be right for
Renal Impairment in Hepatorenal Syndrome
National Hepatology & Tropical Medicine Research Institute 60
Early research (Phase 1)Ended earlyNCT01906307
What this trial is testing

LJPC-501 in Patients With Hepatorenal Syndrome

Who this might be right for
Hepatorenal Syndrome Type I and Type II
La Jolla Pharmaceutical Company 6
Not applicableTemporarily pausedNCT04898010
What this trial is testing

The Selective Cytopheretic Device (SCD) for Acute Kidney Injury (AKI) and Hepatorenal Syndrome (HRS) Type I

Who this might be right for
Acute Kidney InjuryHepatorenal Syndrome
Lenar Yessayan 10
Not applicableEnded earlyNCT02123576
What this trial is testing

Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline

Who this might be right for
Hepatorenal Syndrome
Patrick Northup, MD 12
Large-scale testing (Phase 3)UnknownNCT00742690
What this trial is testing

Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome

Who this might be right for
CirrhosisType 1 Hepatorenal Syndrome
University of Padova 70
Large-scale testing (Phase 3)Study completedNCT02770716
What this trial is testing

Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1

Who this might be right for
Hepatorenal Syndrome
Mallinckrodt 300
Large-scale testing (Phase 3)Ended earlyNCT00742339
What this trial is testing

Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome

Who this might be right for
CirrhosisHepatorenal Syndrome
University of Padova 49
Large-scale testing (Phase 3)Study completedNCT01143246
What this trial is testing

A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin

Who this might be right for
Hepatorenal Syndrome
Mallinckrodt 196
Post-approval studies (Phase 4)UnknownNCT01530711
What this trial is testing

Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response

Who this might be right for
CirrhosisHepatorenal Syndrome Type I
Pere Gines 40
Large-scale testing (Phase 3)Study completedNCT03822091
What this trial is testing

Terlipressin Infusion Alone Vs Terlipressin With Noradrenaline Infusion In The Treatment of Hepatorenal Syndrome Type 1

Who this might be right for
Type 1 HEPATO RENAL SYNDROME(HRS)
Post Graduate Institute of Medical Education and Research, Chandigarh 60
Testing effectiveness (Phase 2)Study completedNCT01373606
What this trial is testing

Terlipressin in Patients With Hepatorenal Syndrome Type 1

Who this might be right for
Hepatorenal Syndrome Type 1
Ferring Pharmaceuticals 8
Large-scale testing (Phase 3)Study completedNCT00089570
What this trial is testing

Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1

Who this might be right for
Hepatorenal Syndrome
Mallinckrodt 112

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation